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Abstract
Toxoplasma gondii is an obligate intracellular parasite of animal cells. Infection of humans is
common and may result in devastating disease, especially in immunocompromised individuals.
Despite previous reports that N-glycosylation of proteins may be a rare post-translational
modification in this and related organisms, we demonstrate that it is actually quite prevalent in
Toxoplasma. N-glycosylation is completely inhibited by treatment of parasites with tunicamycin, but
this does not appear to exert its major effect on the parasites until they have egressed from their host
cells. Although the tunicamycin-treated parasites appear structurally normal at this time they are not
motile and mostly incapable of invading new host cells. The few tunicamycin-treated parasites that
do invade are severely affected in their ability to replicate and accumulate with a distended
endoplasmic reticulum, deformed nuclei, and without recognizable late secretory organelles. We
provide experimental evidence that indicate that Toxoplasma N-glycans differ structurally from those
in other eukaryotes.
1. Introduction
The protozoan parasite Toxoplasma gondii is an obligate intracellular parasite of humans and
other animals. Infection with this parasite is common and can result in serious disease, although
this is most likely to occur in individuals with a deficient immune system or in first-trimester
fetuses [1,2]. Infection is typically initiated by the ingestion of food contaminated with either
Toxoplasma oocysts or tissue cysts, containing sporozoites and bradyzoites respectively. Once
inside the host, these differentiate into the rapid replicating tachyzoites that spread throughout
the infected host [1,2]. Unlike other intracellular parasites that gain access to host cells through
co-opting their endocytic or phagocytic apparatus, Toxoplasma and other apicomplexan
parasites actively penetrate their host cells. In this process, they attach to the plasma membrane
of host cells, and subsequently penetrate them while creating a vacuole, the parasitophorous
vacuole, that they reside in throughout their stay inside the host cell [3].
All of these steps are intimately coupled to the secretion of material from the parasite.
Toxoplasma tachyzoites contain an extensive secretory system consisting of an extensive
endoplasmic reticulum, a Golgi apparatus, and multiple specialized late secretory organelles:
the micronemes, dense granules, and rhoptries. Microneme proteins are required for parasite
binding to host cells [4] but the exact function of the numerous rhoptry and dense granule
proteins is unknown. Most rhoptry proteins are inserted into the PVM [5] but some are injected
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into the host cell proper where they play a clear role in parasite virulence [6-8]. Dense granule
proteins are secreted post-invasion and are found in the PV space and inserted into the PV
membrane [3]. Although certain dense granule proteins are believed to be involved in purine
salvage from host cells [9], the specific functions for most of these proteins or their importance
to parasite survival remains unclear.
The post-translational modification of proteins by the addition of N and O-linked
oligosaccharides is common in most eukaryotes studied to date. With few exceptions [10],
these modifications are usually observed on proteins in the secretory pathway of cells. They
are added onto proteins either during their translocation into the ER, in the case of N-linked
oligosaccharides, or during their transport through the Golgi complex, in the case of the O-
linked oligosaccharides. The protein-linked oligosaccharides are subsequently modified to
various extents as they traverse the secretory pathway to their final destination. The type and
the extent of these modifications vary from species to species and, within a given species, from
tissue to tissue and during development. The protein-linked oligosaccharides have many
important roles in eukaryotes. Within individual cells, these oligosaccharides and their
modifications play a critical role in the correct folding of proteins and their export from the
ER [11], and in the correct intracellular targeting of proteins [12]. Within the animal, the
protein-linked oligosaccharides play diverse and important roles in all processes involving cell-
cell interactions [13]. Finally, protein-linked oligosaccharides also play important roles in the
interaction of many viral, bacterial and protozoan pathogens with their host organisms [13].
Despite the importance of N-glycosylation of proteins in other eukaryotic genera, several
studies have suggested that this post-translational modification is a rare event in apicomplexan
parasites [14-17]. In spite of this, the apicomplexan genomes do appear to contain genes
encoding at least a number of the core enzymes required for synthesis of the dolichol-linked
precursor oligosaccharide as well as the Rft1 flippase and members of the OST complex
[18]. However, the number of proteins where the presence of N-linked oligosaccharides has
been demonstrated experimentally is limited to 2 in Toxoplasma [14,19], 2-3 in Plasmodium
falciparum [17] and none in other apicomplexans. In the present study, we demonstrate that
N-glycosylation of proteins is actually very common in Toxoplasma gondii and that this
modification is necessary for parasite growth. We also demonstrate that the structure of N-
linked oligosaccharides of Toxoplasma differs from that in other eukaryotes.
2. Materials and Methods
2.1. Reagents and antibodies
All reagents were purchased from either Fisher Scientific (Germantown, MD) or Sigma (St.
Louis, MO) unless indicated otherwise. Monoclonal anti bodies to Gra1 (T52B4), Gra2
(T41F5), SAG2 (T43G11), MIC2 (T34A11), MIC3 (T42F3), gp23 (T42E12), and ROP8
(T52D1) were generous gifts of Dr. Jean Francois Dubremetz (Université de Montpellier,
Montpellier, France). The SAG1 monoclonal antibody was purchased from Argene (North
Massapequa, N.Y.). The generation of antisera to NTPase I and II has been described previously
[9]. The monoclonal antibody HC10 was a generous gift of Dr. Frelinger (University of North
Carolina, Chapel Hill, NC).
2.2. Culture of host cells and Toxoplasma tachyzoites
Toxoplasma gondii tachyzoites of the RH strain were maintained in confluent monolayers of
human foreskin fibroblasts (HFF). The latter were maintained in α-MEM medium with
glutamine, penicillin and streptomycin (Invitrogen, Carlsbad, CA ) containing 2% fetal bovine
serum (Hyclone, Logan, UT). Toxoplasma tachyzoites were maintained by serial passage on
HFF cell monolayers every 2-3 days.
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HFF monolayers to be used for experiments with tunicamycin were used at least 12 days after
seeding ∼105 freshly trypsinized cells per cm2. At this stage, the HFF cells were found to be
entirely resistant to the effects of tunicamycin for at least 96 hours as judged by the following
criteria: cell morphology, replating efficiency, Trypan blue exclusion, and a LIVE/DEAD
Viability/Cytotoxicity Kit (Invitrogen, Carlsbad, CA). Tunicamycin titration were performed
by incubating 2 × 105 parasites with confluent HFF monolayers in 25 cm2 flasks containing 4
ml complete medium with the indicated concentrations of tunicamycin or DMSO for 30
minutes, after which the medium was replaced with fresh medium containing the same
concentration of tunicamycin or DMSO. After 2, 24, or 48 hours incubation at 37°C, cells and
parasites were collected by scraping, passed through an 18 and 21G needles to disrupt clumps,
collected by centrifugation for 5 minutes at 2000 rpm, resuspended in 2 ml PBS and counted
using a hemocytometer. All incubations were performed in triplicate.
Control or tunicamycin-treated parasites collected after 48 hours were subsequently tested for
their ability to infect and replicate in fresh HFF monolayers in the same manner as described
above.
The isolated parasites were also tested for their ability to perform gliding motility and to attach
to and invade HFF cells as described before [22].
2.4. Fluorescence and electron microscopy
For fluorescence microscopy, free parasites attached to poly-L-lysine coated coverslips or
infected HFF cells were fixed in cold (−20°C) methanol, or in 3% paraformaldehyde in PBS
followed by permeabilization in 0.5% Triton X-100 in PBS. Incubation with primary and
secondary antibodies were performed as described [19]. For lectin overlays, fixed parasites or
parasite-infected cells were incubate with biotinylated lectins (Vector Laboratories,
Burlingame, CA) diluted 1:500 in 3% BSA in PBS followed by incubation with Texas Red-
conjugated streptavidin (Invitrogen) diluted 1:1000 in the same buffer. Images were captured
using an epifluorescence Nikon Eclipse TE-2000 microscope (Nikon Inc., Melville, NY) and
a Hamamatsu 1394 cooled digital CCD camera (Hamamatsu) and Metamorph® imaging
software (Universal Imaging Corp.). Adobe Photoshop® (Adobe Systems Inc., San Jose, CA)
was used to crop images.
For electron microscopy, Toxoplasma-infected HFF cells were washed twice in 0.1 M sodium
cacodylate pH 7.4 and fixed overnight at 4°C in 2% glutaraldehyde in 0.1 M sodium cacodylate
pH 7.4. After staining in 1% osmium tetroxide and dehydration in 50-100% ethanol, the
samples were embedded in epon. The polymerized bocks were sectioned at 60 nm with a Leica
Ultracut UCT ultramicrotome (Leica Microsystems Inc., Bannockburn, IL). Sections were
stained with 2% uranyl acetate and Sato's lead stain, and viewed on an FEI Tecnai 12 electron
microscope (FEI Company, Hillsboro, OR). Images were collected with a Gatan model 794
multi-scan digital camera (Gatan Inc., Pleasanton, CA).
2.5. Lectin overlays
Protein samples corresponding to 2 × 106 parasites or 5 × 105 HFF cells were separated by
SDS-PAGE and transferred to nitrocellulose. This was blocked in 3% BSA in Tris-buffered
saline with 0.1% Tween 20 (TBST) and incubated for one hour with biotinylated concanavalin-
A or Dolichos biflorus agglutinin (Vector, Burlingame, CA) diluted 1:2000 and 1:1000 in
TBST, respectively. Following incubation with IRDye800CW-conjugated streptavidin (Li-
COR Biosciences, Lincoln, NE) the blots were scanned with a Li-COR Odyssey (Li-COR
Biosciences).
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Where indicated, total parasite lysates were also digested prior to SDS-PAGE with PNGase F
as suggested by the manufacturer (NEB).
2.6. Metabolic labeling and immunoprecipitation
For long-term labeling of proteins, Toxoplasma-infected or uninfected HFF cells (in 25 cm2
flasks) were washed twice with cysteine/methionine-free DMEM medium (Invitrogen) and
incubated for 16-18 hours at 37°C in 3 ml cysteine /methionine-free DMEM medium
containing 3% dialyzed fetal bovine serum and 358 μCi [35S] methionine/cysteine (Pro-Mix
[35S] in vitro cell labeling mix, GE Healthcare BioSciences Corp., Piscataway, NJ).
Tunicamycin (EMD Biochemicals Inc., San Diego, CA) was added to 5 μg/ml where indicated.
Cells were collected by scraping with a rubber policeman, collected by centrifugation for 5
minutes at 400 × g, washed once in PBS and frozen in liquid nitrogen.
For pulse-chase experiments, Toxoplasma-infected or uninfected HFF cells were washed twice
in cysteine/methionine-free DMEM and subsequently gently scraped into 2 ml of the same
medium using a rubber policeman. Cells were collected by centrifugation for 5 minutes at 400
× g, resuspended in 1 ml cysteine/methionine-free DMEM containing 3% dialyzed fetal bovine
serum, and incubated for 30 minutes at 37°C. Pulse labeling was initiated by the addition of
358 μCi [35S] methionine/cysteine and incubated at 37°C for 10 minutes. Subsequently,
methionine and cysteine were added to a final concentration of 0.1 mM. Samples (0.45 ml)
were removed, placed on ice, centrifuged for 1 minute at 14,000 × g and 4°C, and the resulting
pellets frozen in liquid nitrogen. The remainder was incubated for an additional 60 minutes at
37°C after which 0.45 ml was removed, centrifuged as described above and also frozen in
liquid nitrogen.
Cell pellets were resuspended in 1% SDS in water and heated for 5 minutes at 95°C. Samples
were diluted by the addition of 9 volumes of 1% Triton X-100 in 150 mM NaCl, 5 mM EDTA,
50 mM Tris-HCl pH 8 (TNET) and insoluble material was removed by centrifugation for 10
minutes at 14,000 × g and 4°C. GAP50 and HLA class I heavy chains were immunoprecipitated
by the addition of a rabbit-anti-GAP50 antiserum and the HC10 monoclonal antibody [23].
After 60 minutes on ice, 25 μl of protein-A agarose (Zymed, S. San Francisco, CA) was added
followed by an additional incubation for 30 minutes at 4°C. Protein-A beads were washed three
times in TNET buffer.
The immunoprecipitated material was treated where indicated with either endoglycosidase H
or PNGase F (New England Biolabs, Beverly, MA) according to manufacturers' instructions.
Samples were analyzed by SDS-PAGE and fluorography with EN3HANCE (Perkin Elmer,
Boston, MA).
3. Results
3.1. N and O-linked glycosylation of proteins is common in Toxoplasma gondii
We previously observed that GAP50, the membrane anchor for the myosin XIV motor complex
in Toxoplasma gondii, contains multiple N-linked oligosaccharides [19]. Previous studies by
Schwarz and colleagues had demonstrated [3H] mannose incorporation into only a small
number of Toxoplasma proteins, one of which was identified as the cell surface protein gp23
[14]. In light of these observations and in the context of devising alternative purification
strategies for the myosin motor complex from Toxoplasma, we analyzed parasites by western
blotting and fluorescence microscopy for the presence of proteins with N-linked
oligosaccharides using biotinylated lectins. Specifically, we used the mannose-specific lectin
concanavalin-A (con-A) to detect N-glycosylated proteins and the N-acetylgalactosamine-
specific lectin from Dolichos biflorus lectin (DBA) to detect O-glycosylated proteins.
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Total Toxoplasma tachyzoite lysates were fractionated by SDS-PAGE, transferred to
nitrocellulose, and incubated with the biotinylated lectins. Host cell lysates were analyzed in
parallel to control for possible contamination of the parasite preparation. We also compared
reactivity of lectins with untreated and PNGase F-treated Toxoplasma protein preparations to
ensure that all reactivity was due to the presence of N-linked oligosaccharides. To our surprise,
we found that Toxoplasma tachyzoites contained a large number of proteins reactive with con-
A and DBA, indicating that N and O-glycosylation of proteins is as common in T. gondii as it
is in other eukaryotes (Fig. 1). Based on the number of protein species reactive with con-A,
we estimate that Toxoplasma tachyzoites contain at least 11 major N-glycosylated proteins and
multiple minor ones. The reactivity of con-A with the parasite proteins is due to the presence
of N-linked oligosaccharides on these proteins as it is absent in parasite lysates pretreated with
the N-glycan specific enzyme PNGase F (Fig. 1). The absence of labeling is not due to
degradation or loss of protein as the PNGaseF treated and non-treated samples contained
similar quantities of the membrane skeleton protein IMC1, the myosin light chain MLC1, and
GAP50. As the latter is known to be N-glycosylated, its decrease in MWapp upon PNGase F
digestion serves as an internal control for this enzyme. Based on a similar analysis with DBA,
we estimate that more than 15 Toxoplasma proteins contain O-linked oligosaccharides exist in
Toxoplasma. The reactivity of DBA with Toxoplasma proteins was, as expected, not affected
by PNGase F treatment (Fig. 1). Surprisingly, the reactivity of DBA with Toxoplasma proteins
was not affected by digestion with O-glycanase (data not shown). Incubation of parasite
proteins with anhydrous trifluoromethanesulfonic acid, a treatment that is used to hydrolyze
both N and O-linked oligosaccharides, also did not affect reactivity with DBA under conditions
where all reactivity with con-A was lost (data not shown).
The observations were found to be very consistent between different parasite preparations and
therefore indicate that both N and O-linked glycosylation of proteins in T. gondii is far more
common than was previously believed.
3.2. N and O-glycosylated proteins are found throughout parasite
As stated above, the majority of N and O-glycosylated proteins in other eukaryotes are found
along the secretory and endocytic/phagocytic pathways, on the plasma membrane and in the
surrounding medium. In order to determine the general location of N and O-glycosylated
proteins in Toxoplasma tachyzoites, we probed fixed extracellular parasites with the various
biotinylated lectins used in Fig. 1, followed by a Texas Red-conjugated streptavidin. We
observed con-A-reactive material in multiple structures throughout extracellular parasites that
overlapped to various extents with all markers for the secretory pathway (Supplementary Fig.
1). It was impossible to determine if any of the con-A reactive proteins of Toxoplasma were
secreted into the parasitophorous vacuole surrounding intracellular parasites as binding of this
lectin to host cell glycoproteins effectively obscures any interaction with parasite
glycoproteins. DBA-reactive material appeared to be confined to structures found between the
parasite nucleus and the anterior end of the parasites. These DBA-positive structures did not
obviously co-localize with any makers of known secretary organelles in Toxoplasma
suggesting they may represent structures that have not been characterized to date (data not
shown). Together with the data shown in Fig. 1, these data demonstrate that Toxoplasma
synthesizes a large number of proteins with N and O-linked glycans that are found throughout
the secretory pathway of the parasite.
3.3. N-glycosylation is essential for Toxoplasma viability
The data in the previous sections demonstrate that N-linked glycosylation is a common post-
translational modification of Toxoplasma proteins. To determine if N-glycosylation of proteins
is as critical to Toxoplasma survival as it is in other eukaryotes, we tested the effect of
tunicamycin on protein glycosylation and parasite growth.
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We monitored the effect of tunicamycin on N-glycosylation of proteins in Toxoplasma using
GAP50, the only characterized N-glycosylated protein in the parasite. GAP50 was
immunoprecipitated from parasites that had been metabolically labeled with [35S] methionine
in the absence or presence of 5 μg/ml tunicamycin, a concentration that was sufficient to block
glycosylation of HLA class I antigens in uninfected HFF cells (not shown). As can be seen in
Fig. 2, this concentration of tunicamycin also suffices to block N-glycosylation of GAP50
completely.
Treatment of other cells types with tunicamycin typically results in the accumulation of non-
glycosylated and unfolded proteins in the endoplasmic reticulum and cell death [20].
Completely confluent HFF cells, in sharp contrast to non-confluent cultures, were not
obviously affected by treatment with up to 20 μg/ml tunicamycin for 72 hours as judged by
intactness of the monolayer, cell morphology, cell integrity (as judged by trypan blue exclusion
and a LIVE/DEAD cell viability assay), and cell viability (Supplementary Fig. 2). As
Toxoplasma infection and replication was not affected by HFF cell density, the use of confluent
HFF cells allowed us to determine the long-term effect of tunicamycin on Toxoplasma
replication and morphology.
Treatment of Toxoplasma-infected, confluent HFF cultures with 5 μg/ml tunicamycin resulted
in the complete inhibition of GAP50 N-glycosylation as judged by immunoblot (Fig. 3A)
confirming that the N-glycosylation machinery of Toxoplasma is sensitive to tunicamycin
under these experimental conditions. To determine how long-term inhibition of N-
glycosylation affects Toxoplasma viability and structure, we infected confluent HFF
monolayers with Toxoplasma and treated these with different concentrations of tunicamycin.
A typical Toxoplasma infection cycle, from the initial infection through parasite egress, lasts
48 hours in HFF cells. As we did not know the kinetics with which tunicamycin affects the
parasite, we performed the tunicamycin titrations over a total period of 96 hours. This was
divided into two 48 hour infection cycles in which parasites obtained from the first 48 hour
cycle (stage 1) were used to re-infect fresh HFF monolayers and followed for an additional 48
hours (stage 2). Tunicamycin concentrations were maintained at identical levels in both stages.
Parasites were harvested at different time points and counted.
During the first 48 hour infection cycle (Stage 1, Fig. 3B), treatment with increasing
concentrations of tunicamycin resulted in a decreased parasite yield. The maximal effect was
observed with 5 μg/ml tunicamycin but even at higher concentrations we did not observe a
complete inhibition of parasite replication. This was a surprising finding in that inhibition of
glycosylation was complete at these concentrations (Fig. 3A). In stage 2 of this experiment,
we determined if the parasites that had been grown for 48 hours in various tunicamycin
concentrations in stage 1 were still capable of host cell infection and replication. As can be
seen in figure 3B, parasites that were grown in the presence of as little as 5 μg/ml tunicamycin
in stage 1 were incapable of growth in new cultures during stage 2.
This observation could be explained by tunicamycin inducing more or less specific defects in
parasite motility, host cell attachment or invasion. As can be seen in Figs. 3C and 3D,
tunicamycin-treated Toxoplasma tachyzoites appear to be severely defective in all three assays.
A small fraction of the tunicamycin-treated parasites did infect the new monolayer in stage 2
of the experiment but the vast majority (>95%) failed to replicate. The few that did replicate
only gave rise to small vacuoles containing 4 or less parasites. Treatment of Toxoplasma with
10 μg/ml tunicamycin for 48 hours does not result in any obvious changes in either the
expression level or distribution of GAP50, the one well-characterized N-glycosylated protein
in Toxoplasma (Fig. 4). Similarly, we did not observe obvious effects on the amount or
localization of marker proteins for the parasite plasma membrane, the endoplasmic reticulum,
or the three major late secretory organelles: the rhoptries, dense granules, and micronemes
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(Supplementary Fig 1B). The apicoplast, a plastid-like organelle embedded in the secretory
apparatus of apicomplexan parasites, also did not appear to be affected as judged by staining
of the organellar DNA with DAPI. The same staining also revealed no obvious effects of the
tunicamycin treatment on nuclear morphology.
As indicated above, treatment of Toxoplasma tachyzoites with tunicamycin for 48 hours
renders the parasites largely incapable of invading into new host cells. When the few parasites
that had invaded were analyzed after an additional 48 hours of tunicamycin treatment, effects
on parasite morphology, protein expression, and protein distribution were more pronounced.
Expression of GAP50 and the dense granule protein GRA3 were greatly diminished compared
to untreated parasites (Fig. 4, Supplementary Fig. 3). The expression level of the plasma
membrane protein SAG1 and the microneme protein MIC2 was not noticeably affected but
marked intracellular accumulations of both proteins were evident (Supplementary Fig. 3A). In
the case of MIC2, the accumulation appeared to occur in the nuclear envelope and endoplasmic
reticulum. SAG1, on the other hand, accumulated in anterior structures that did not contain
marker proteins for any of the known secretory organelles in the parasite. Tunicamycin
treatment did not have a noticeable impact on either the expression level or transport of either
Toxoplasma BiP or the rhoptry protein ROP2. Nuclear morphology was clearly affected in the
vast majority of parasites as was the frequency with which DAPI-positive apicoplasts were
observed. Unlike what is seen in animal cells, tunicamycin treatment did not induce condensed
nuclei in Toxoplasma.
We used transmission electron microscopy to analyze the effect of tunicamycin treatment on
the subcellular structure of Toxoplasma tachyzoites (Fig. 5). After 48 hours treatment with 10
μg/ml tunicamycin, we did observed only one reproducible structural effect on Toxoplasma in
that the nuclear envelope of tunicamycin-treated parasites consistently appeared slightly
distended (Fig. 5B, inset). After 96 hours, the impact of tunicamycin treatment was obvious,
with an extensive distension of the nuclear envelope and endoplasmic reticulum, and an
absence of recognizable dense granules and rhoptries (Fig. 5C). The latter observation indicates
that the ROP2-positive structures observed by light microscopy either do not represent normal
rhoptries or that the structures of these organelles has changed beyond recognition. A defined
nucleus was also absent from the parasites at this stage which is consistent with the light
microscopic observations in Supplementary Fig. 3.
3.4. Other N-glycosylated proteins of Toxoplasma
In the experiments described above, we used the integral membrane protein GAP50 to monitor
the effectiveness with which tunicamycin blocks N-glycosylation in Toxoplasma tachyzoites.
As the data in Fig. 1 indicate, multiple N-glycosylated proteins exist in these organisms. The
report by Odenthal-Schnittler et al [14] indicates that gp23 may be one of these, although we
did not observe an obvious conA-reactive glycoprotein in the 23 kDa molecular weight range
(Fig. 1A). When we analyzed gp23 directly for the presence of N-linked oligosaccharides by
PNGase F digestion, however, we did not observe any noticeable change in its MWapp in SDS-
PAGE (Supplementary Fig. 4A). The MWapp was also not noticeably affected in tunicamycin-
treated parasites (data not shown).
To identify other potential N-glycosylated Toxoplasma proteins, we analyzed predicted protein
sequences generated form the Toxoplasma genome project (toxodb.org) for the presence of
additional candidate N-glycosylated proteins. Specifically, we searched the database for
protein sequences predicted to possess N-terminal signal sequences and this subset was
subsequently analyzed for candidates that had consensus N-glycosylation sites (N-X-S/T,
where X is not a proline). Multiple candidates were identified using this strategy including a
number of known Toxoplasma secretory or plasma membrane proteins (Supplementary table
1). We analyzed a number of these candidates for the presence of N-linked oligosaccharides
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by comparing their MWapp before and after digestion with PNGase F. As can be seen in
Supplementary table 1 and Supplementary Fig. 4B, none of the candidate proteins appeared
N-glycosylated based on this criterion. This observation suggests that, apart from GAP50, the
Toxoplasma glycoproteins identified in Fig. 1 may represent novel parasite proteins. We have
initiated the identification of these proteins using mass spectroscopy of lectin-affinity purified
parasite proteins.
3.5. N-linked oligosaccharides of Toxoplasma differ from those in other eukaryotes
In most eukaryotes, the N-linked oligosaccharides on proteins exported from the ER are
modified extensively through the addition and/or removal of sugar residues or their derivatives.
Typically, this results in noticeable alteration in the apparent molecular weight (MWapp) of
these proteins during SDS-PAGE. We analyzed whether there were any major alterations in
the MWapp of GAP50 during a pulse-chase experiment. As can be seen in Fig. 6, there is no
obvious change in the motility of GAP50 in this experiment suggesting that, although
processing the N-linked glycans may be occurring during the experiment, these are not
substantial enough to alter the MWapp of GAP50.
A commonly used method to observe at least part of N-linked glycan processing of a protein
during its intracellular transport from the ER to the Golgi complex is to incubate the
glycoprotein with the enzyme endoglycosidase H (endoH). Whereas the N-linked
oligosaccharides found on glycoproteins in the ER are sensitive to cleavage by this enzyme,
processing of the oligosaccharide in the Golgi complex renders it endoH-resistant. This is
demonstrated in the control experiment shown in Fig. 6, were we analyzed the endoH-
sensitivity of the N-linked glycans on HLA class I heavy chain that was immunoprecipitated
in parallel from host cells. When we analyzed whether there was a similar change in the
sensitivity of N-linked glycans on GAP50 to endoH, we found to our surprise that these were
endoH-resistant at all times. This effect is not due to their inaccessibility to endoH as the
oligosaccharides were readily removed by PNGase F, a glycosidase that removes all N-linked
glycans from proteins. Taken together with our previous observations these data indicate that
N-glycosylation is a common post-translational modification of proteins in Toxoplasma
gondii but that the structure of these glycans differs substantially from that encountered to date
in animals, plants, and other unicellular organisms.
4. Discussion
Protein glycosylation is a common post-translational modification of proteins in all eukaryotic
cells studied to date and is known to play important roles in the quality control of protein folding
in the endoplasmic reticulum, in the control of intracellular trafficking of proteins, and in the
regulation of cell-cell and cell-substrate interactions. Protein glycosylation also plays a critical
role in the interaction of various pathogens with their host cells [13]. Despite this, neither the
existence of N-glycosylation in Toxoplasma nor its role in the parasite's cellular processes or
ability to cause disease has received a lot of attention beyond the initial reports by Schwarz
and co-workers [14,15]. As a result of this, little consideration has been given to the possible
role of Toxoplasma N-linked glycans in the efficacy of potential vaccine candidates or in the
immune response to Toxoplasma in general.
A careful analysis by Samuelson and colleagues [18] of the genomic and EST sequences
obtained in the Toxoplasma genome project indicates that Toxoplasma, and its close relatives
Cryptosporidium and the malaria parasite Plasmodium, do in fact possess the general
enzymatic machinery to synthesize dolichol-linked precursors for the N-linked
oligosaccharides as well as the machinery to transfer it to nascent polypeptide chains. Their
analysis did not result in the identification of homologues for all of the enzymes known to be
involved in N-glycan synthesis in other eukaryotes. Whether this reflects a true absence of
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these enzyme activities in the parasites, a lack of their evolutionary conservation or the
incomplete nature of the databases remains to be determined. We have repeated the analysis
performed by Samuelson et al using more recent versions of the Toxoplasma sequence
databases. Our analysis largely confirms their findings and in fact gave rise to the identification
of a homolog for only one additional enzyme (Supplementary Fig. 5).
Our lectin overlay experiments suggest that Toxoplasma tachyzoites contain at least 11 major
and multiple minor N-glycosylated proteins (Fig. 1). Thus far, only two Toxoplasma proteins
have been reported to be N-glycosylated. The presence of N-linked glycans on GAP50, the
membrane anchor for the myosin XIV motor complex in the parasite, was demonstrated
through digestion with PNGase F and through its sensitivity to tunicamycin. (Figs. 1 and 2).
The other protein, gp23, is a GPI-anchored Toxoplasma surface protein which has not been
characterized by molecular cloning [14]. The presence of N-linked oligosaccharides on this
protein was based on the incorporation of radiolabeled sugars and their release by PNGase F
[14]. The authors of that work also found that the radiolabeled oligosaccharides were resistant
to endo H, but interpreted this to mean that, like in higher eukaryotes, the oligosaccharides had
matured to a complex type structure. In the light of our findings and the analysis by Samuelson
et al, it is also possible that the gp23 oligosaccharides are endoH-resistant because their
structure lacks the prerequisite mannose residue. In our hands, gp23 did not appear to be
affected by treatment with tunicamycin or PNGase F, however. Further analysis of gp23 is
needed to address these discrepancies.
Like all in other eukaryote cells studied to date, N-liked glycosylation of proteins is essential
for the survival of Toxoplasma. Treatment of the parasite with tunicamycin results in parasite
death although this occurs with unusual kinetics. When extracellular or intracellular
Toxoplasma tachyzoites are treated with tunicamycin, N-glycosylation is immediately
inhibited (Fig. 2). This does not result in an immediate block in the ability of the parasites to
invade into host cells, but their ensuing replication is blocked by more than 950% (Fig. 3B).
Apart from having a slightly distended nuclear envelope the resulting parasites appear normal
at the ultrastructural level and their major secretory organelles do not appear affected (Fig.
5B). These parasites are almost completely incapable of invading new host cells, however (Fig.
3B). The few parasites that do invade replicate only once or twice and accumulate with
deformed nuclei, vastly distended endoplasmic reticulum and nuclear envelope, and without
recognizable late secretory organelles (Fig. 4, 5C and Supplementary Fig. 3).
The latter observations are consistent with the general disruption of the secretory pathways
typically observed in other eukaryotes [12]. There are a number of possible explanations for
the observation that disruption of N-glycosylation by tunicamycin does not result in a large
effect on parasite ultrastructure or replication rate during the first 48 hours of incubation, but
a very substantial effect on the subsequent motility and host cell invasion. Our data are most
consistent with a model in which most Toxoplasma glycoproteins are not important for parasite
growth or replication inside animal host cells, but are critical for the processes that follow their
release from these cells: motility and host cell invasion.
The analysis of the Toxoplasma genome for the presence of the various enzymes (ALG protein
homologs) known to be required for the synthesis of the dolichol-linked precursor
oligosaccharide suggests that the parasite may not be able to synthesize the structure typically
encountered in animal cells and yeasts (Supplementary Fig. 5, Samuelson et al [18], this study).
Specifically, homologs of the genes encoding ALG3p (dolichyl-P-Man:Man5GlcNAc2-PP-
dolichyl α(1-3)-mannosyltransferase), ALG9p (dolichyl-P-Man:Man6GlcNAc2-PP-dolichyl
α(1-2)-mannosyltransferase) and ALG12p (dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl-α
(1-6)-mannosyltransferase) appear to be lacking from the Toxoplasma genome (Supplementary
Fig. 5). As the glucosyltransferase responsible for the addition of the three terminal glucose
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residues to the precursor oligosaccharide are present in the parasite genome, it would suggest
that N-glycosylation of proteins in Toxoplasma would involve the structure shown in Fig. 7.
The absence of gene products with homology to known enzymes from Toxoplasma does not
prove, however, that a particular enzyme activity is actually absent as it may be supplied by a
structurally unrelated, parasite-specific enzyme. The experiments shown in Fig. 6 demonstrate
that this is unlikely to be the case. Endoglycosidase H requires Man-α(1-3)-Man-α(1-6)-Man-
β(1-4)-GlcNAc-β(1-4)-GlcNAc-Asn as minimal structure in order to cleave the N-linked
oligosaccharide from a glycoprotein [21]. The observation that the Toxoplasma glycoprotein
is always resistant to the action of endoglycosidase H, but not PNGase F, indicates that this
particular mannose is indeed absent from Toxoplasma N-linked oligosaccharides, supporting
the notion that an ALG3-like enzyme activity is absent from the parasite.
We have not addressed the presence of N-linked oligosaccharides on protein in Plasmodium
and Cryptosporidium species at this time. Whereas the Cryptosporidium genome is predicted
to encode homologs of the same ALG genes present in Toxoplasma and is therefore likely to
possess similar N-linked oligosaccharides( [18] and Supplementary Fig. 5). This is not the case
in Plasmodium species where the genome does not appear to encode any of ALG gene
homologs except for ALG7 [18]. There have been conflicting reports on the presence of N-
linked oligosaccharides on Plasmodium proteins. Dieckmann-Schnittler et al could not detect
any evidence for the presence of ALG7 activity in P. falciparum lysates or oligosaccharide
transferase activity, nor could they detect any evidence for sensitivity to tunicamycin [16].
Although this would appear to be in conflict with the analysis of Samuelson et al, it is important
to remember that biochemical analyses of Plasmodium extracts is complicated by the small
yield and by the extensive contamination by host cell material. In contrast to these observations,
Kimura et al reported that replication of P. falciparum is moderately affected by the presence
of tunicamycin [17] and that a small number of con-A reactive proteins are present in parasite-
infected erythrocytes. The latter observation is surprising in that the analysis by Samuelson et
al suggests that the Plasmodium genome does not posses genes encoding the mannosyl
transferases necessary to generate a con-A-reactive high mannose oligosaccharide are absent
[18].
Our studies indicate that N-glycosylation of proteins is a common post-translational
modification in Toxoplasma and that the structure of the oligosaccharides lacks a number of
the elements typically encountered in other species. We do not know, however, the identity or
location of the N-glycosylated proteins other than GAP50, nor do we know the extent to which
the N-linked oligosaccharides are modified post-translationally. Considering the clinical
importance of Toxoplasma and related apicomplexan parasites like Plasmodium and
Cryptosporidium it is evident that further study of N-glycosylation in these organisms may
yield novel diagnostic and therapeutic strategies. The analysis of N-linked oligosaccharide
synthesis and structure in these parasites is also likely to shed more light on the role of this
post-translational modification in general.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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N and O-glycosylation of proteins are common post-translational modifications in
Toxoplasma tachyzoites.
Lysates of purified tachyzoites were incubated in the absence (Control) or presence (PNGase
F) of PNGase F for 16 hours at 37°C, fractionated by SDS-PAGE on 12% (A) or 7.5% (B)
gels, and transferred to nitrocellulose. Blots were probed with biotinylated lectins
concanavalin-A (con-A) and Dolichos biflorus agglutinin (DBA), and with monospecific
antisera to the Toxoplasma glycoprotein GAP50 and the cytoplasmic proteins MLC1 and
IMC1. Arrowheads indicate the con-A-reactive parasite proteins that are PNGase F sensitive.
GAP50+OS and GAP50−OS refer the fully N-glycosylated and enzymatically deglycosylated
GAP50, respectively.
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N-glycosylation in Toxoplasma gondii is sensitive to tunicamycin.
GAP50 was immunoprecipitated from Toxoplasma-infected HFF cells that were labeled for
16 hours with [35S] methionine/cysteine in the presence or absence of 5 μg/ml tunicamycin.
GAP50+OS and GAP50−OS refer to fully N-glycosylated and non-glycosylated GAP50,
respectively.
Luk et al. Page 14














N-glycosylation is critical for Toxoplasma survival.
A) GAP50 accumulates in non-glycosylated form after growth of Toxoplasma for 24 hours in
the presence of 5 μgr/ml tunicamycin. GAP50+OS and GAP50−OS refer to fully N-
glycosylated and non-glycosylated GAP50, respectively.
B) The effect of tunicamycin on Toxoplasma cell viability was determined in a two-stage
experiment. In stage 1, confluent HFF monolayers were infected with freshly isolated parasites
in the presence of the indicated concentration of tunicamycin or DMSO. Unattached parasites
were removed by washing after 2 hours at 37°C and the incubation continued in the presence
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or absence of tunicamycin. The number of host cell-associated parasites was determined at the
indicated times.
In stage 2, parasites that had been isolated after 48 hours in the presence or absence of
tunicamycin and used to infect fresh confluent HFF monolayers. Parasite replication was
monitored in the same fashion as in stage 1.
C) Parasites treated for 48 hours with 5 μg/ml tunicamycin are severely defective in gliding
motility. The arrowhead indicates the trail of cell surface protein left behind by the moving
parasite.
D) Tunicamycin-treated (48 hours) parasites are defective in host cell attachment and invasion.
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GAP50 expression and nuclear morphology are affected by long-term treatment with
tunicamycin.
Toxoplasma tachyzoites expressing a GAP50-YFP fusion protein were treated for 48 or 96
hours in the presence or absence of 5 μgr/ml tunicamycin. The membrane skeletal protein IMC1
was visualized by indirect immunofluorescence and the nuclear and apicoplast DNA by
staining with DAPI. The exposure time for GAP50-YFP was 200 msec for the control and 48
hour incubation, and 2 seconds for the 96 hour incubation. Scale bars: 5 μm.
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Inhibition of N-glycosylation and Toxoplasma ultrastructure.
Toxoplasma tachyzoites were incubated in the presence of DMSO (A) or in the presence of (in
the text you stated that you used 10ug/mL; not sure which one is which)5 μg/ml tunicamycin
for (B) 48 hours or (C) 96 hours. Scale bars: 200 nm. Insets show details of the parasite Golgi
complex (GC), nuclear membrane (NM), inner membrane complex (imc), plasma membrane
(PM), dense granules (dg), rhoptries (rh), and micronemes (mn).
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Toxoplasma N-linked oligosaccharides are never sensitive to endoglycosidase H.
Uninfected or Toxoplasma-infected HFF cells were pulse labeled with [35S] methionine/
cysteine for 10 minutes and subsequently chased for 60 minutes in the presence of excess
unlabeled methionine and cysteine. GAP50 and the HLA class I heavy chains were
immunoprecipitated from the Toxoplasma-infected or uninfected HFF cells, respectively, and
subjected to digestion with endoglycosidase H or PNGase F. The positions of the fully
glycosylated (GAP50+OS, HLAHC+OS) and deglycosylated proteins (GAP50-OS, HLAHC-
OS) are indicated.
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A) Structure of the typical core N-linked oligosaccharide on newly synthesized animal and
yeast glycoproteins.
B) Minimal N-linked oligosaccharide structure required for sensitivity to endoglycosidase H
[21].
C) Predicted structure of N-linked oligosaccharide on newly synthesized glycoproteins in
Toxoplasma gondii.
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